Engineered nanovesicles from activated neutrophils with enriched bactericidal proteins have molecular debridement ability and promote infectious wound healing

Abstract

Background: Bacterial infections pose a considerable threat to skin wounds, particularly in the case of challenging-to-treat diabetic wounds. Systemic antibiotics often struggle to penetrate deep wound tissues and topically applied antibiotics may lead to sensitization, necessitating the development of novel approaches for effectively treating germs in deep wound tissues. Neutrophils, the predominant immune cells in the bloodstream, rapidly release an abundance of molecules via degranulation upon activation, which possess the ability to directly eliminate pathogens. This study was designed to develop novel neutrophil cell engineered nanovesicles (NVs) with high production and explore their bactericidal properties and application in promoting infectious wound healing. Methods: Neutrophils were isolated from peripheral blood and activated in vitro via phorbol myristate acetate (PMA) stimulation. Engineered NVs were prepared by sequentially extruding activated neutrophils followed by ultracentrifugation and were compared with neutrophil-derived exosomes in terms of morphology, size distribution and protein contents. The bactericidal effect of NVs in vitro was evaluated using the spread plate technique, LIVE/DEAD backlight bacteria assay and observation of bacterial morphology. The therapeutic effects of NVs in vivo were evaluated using wound contraction area measurements, histopathological examinations, assessments of inflammatory factors and immunochemical staining. Results: Activated neutrophils stimulated with PMA in vitro promptly release a substantial amount of bactericidal proteins. NVs are similar to exosomes in terms of morphology and particle size, but they exhibit a significantly higher enrichment of bactericidal proteins. In vitro, NVs demonstrated a significant bactericidal effect, presumably mediated by the enrichment of bactericidal proteins such as lysozyme. These NVs significantly accelerated wound healing, leading to a marked reduction in bacterial load, downregulation of inflammatory factors and enhanced collagen deposition in a full-thickness infectious skin defect model. Conclusions: We developed engineered NVs derived from activated neutrophils to serve as a novel debridement method targeting bacteria in deep tissues, ultimately promoting infectious wound healing.

Keywords

Neutrophil / Engineered nanovesicles / Molecular debridement / Bactericidal proteins / Infectious wound

References

[1] Verdolino DV, Thomason HA, Fotticchia A, Cartmell S. Wound dressings: curbing inflammation in chronic wound healing. Emerg Top Life Sci. 2021; 5: 523-37.

[2] Leaper D, Assadian O, Edmiston CE. Approach to chronic wound infections. Br J Dermatol. 2015; 173: 351-8.

[3] Bassetti M, Peghin M, Castaldo N, Giacobbe DR. The safety of treatment options for acute bacterial skin and skin structure infections. Expert Opin Drug Saf. 2019; 18: 635-50.

[4] Daeschlein G. Antimicrobial and antiseptic strategies in wound management. Int Wound J. 2013; 10: 9-14.

[5] Frieri M, Kumar K, Boutin A. Antibiotic resistance. Journal of Infection and Public Health. 2017; 10: 369-78.

[6] Madhok BM, Vowden K, Vowden P. New techniques for wound debridement. Int Wound J. 2013; 10: 247-51.

[7] Dayya D, O’Neill OJ, Huedo-Medina TB, Habib N, Moore J, Iyer K. Debridement of diabetic foot ulcers. Adv Wound Care (New Rochelle). 2022; 11: 666-86.

[8] Lehrer RI, Ganz T, Selsted ME, Babior BM, Curnutte JT. Neutrophils and host Defense. Ann Intern Med. 1988; 109: 127-42.

[9] Sun BW, Huang JM. Re-understanding the physiological and pathophysiological roles of neutrophils. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022; 38: 109-13.

[10] Shao Y, Guo Z, Yang Y, Liu L, Huang J, Chen Y, et al. Neutrophil extracellular traps contribute to Myofibroblast differentiation and scar hyperplasia through the toll-like receptor 9/nuclear factor kappa-B/Interleukin-6 pathway. Burns Trauma. 2022; 10: tkac044.

[11] Liew PX, Kubes P. The Neutrophil’s role during health and disease. Physiol Rev. 2019; 99: 1223-48.

[12] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020; 367: eaau6977.

[13] Wang H, Zang J, Zhao Z, Zhang Q, Chen S. The advances of neutrophil-derived effective drug delivery systems: a key review of managing Tumors and inflammation. IJN. 2021; 16: 7663-81.

[14] Jo W, Kim J, Yoon J, Jeong D, Cho S, Jeong H, et al. Large-scale generation of cell-derived Nanovesicles. Nanoscale. 2014; 6: 12056-64.

[15] Jang SC, Kim OY, Yoon CM, Choi DS, Roh TY, Park J, et al. Bioinspired exosome-mimetic Nanovesicles for targeted delivery of chemotherapeutics to malignant Tumors. ACS Nano. 2013; 7: 7698-710.

[16] Jo W, Jeong D, Kim J, Cho S, Jang SC, Han C, et al. Microfluidic fabrication of cell-derived Nanovesicles as endogenous RNA carriers. Lab Chip. 2014; 14: 1261-9.

[17] Gheibi S, Kashfi K, Ghasemi A. A practical guide for induction of Type-2 diabetes in rat: incorporating a high-fat diet and Streptozotocin. Biomed Pharmacother. 2017; 95: 605-13.

[18] Damascena HL, Silveira WAA, Castro MS, Fontes W. Neutrophil activated by the famous and potent PMA (Phorbol Myristate acetate). Cells. 2022; 11: 2889.

[19] Yang Y, Liu L, Guo Z, Li L, Shao Y, Song M, et al. Investigation and assessment of neutrophil dysfunction early after severe burn injury. Burns. 2021; 47: 1851-62.

[20] Li X, Gui R, Li J, Huang R, Shang Y, Zhao Q, et al. Novel multifunctional silver nanocomposite serves as a resistance-reversal agent to synergistically combat Carbapenem-resistant Acinetobacter Baumannii. ACS Appl Mater Interfaces. 2021; 13: 30434-57.

[21] Wang Y, Sun Y, Li W, Tian W, Irini A. High performance of Nanoscaled Fe2O3 Catalyzing UV-Fenton under neutral condition with a low stoichiometry of H2O2: kinetic study and mechanism. Chem Eng J. 2015; 267: 1-8.

[22] Zhao H, Huang J, Li Y, Lv X, Zhou H, Wang H, et al. ROS-scavenging hydrogel to promote healing of bacteria infected diabetic wounds. Biomaterials. 2020; 258: 120286.

[23] Schreml S, Szeimies RM, Prantl L, Karrer S, Landthaler M, Babilas P. Oxygen in acute and chronic wound healing. Br J Dermatol. 2010; 163: 257-68.

[24] Zhong Y, Seidi F, Wang Y, Zheng L, Jin Y, Xiao H. Injectable chitosan hydrogels tailored with antibacterial and antioxidant dual functions for regenerative wound healing. Carbohydr Polym. 2022; 298: 120103.

[25] Diban F, Di Lodovico S, Di Fermo P, D’Ercole S, D’Arcangelo S, Di Giulio M, et al. Biofilms in chronic wound infections: innovative antimicrobial approaches using the In vitro Lubbock chronic wound biofilm model. Int J Mol Sci. 2023; 24: 1004.

[26] Zhang Y, Wang S, Yang Y, Zhao S, You J, Wang J, et al. Scarless wound healing programmed by Core-Shell microneedles. Nat Commun. 2023; 14: 3431.

[27] Timár CI, Lőrincz ÁM, Csépányi-Kömi R, Vályi-Nagy A, Nagy G, Buzás EI, et al. Antibacterial effect of microvesicles released from human neutrophilic granulocytes. Blood. 2013; 121: 510-8.

[28] Yang B, Lin Y, Huang Y, Zhu N, Shen YQ. Extracellular vesicles modulate key signalling pathways in refractory wound healing. Burns Trauma. 2023; 11: tkad039.

[29] Han C, Jeong D, Kim B, Jo W, Kang H, Cho S, et al. Mesenchymal stem cell engineered Nanovesicles for accelerated skin wound closure. ACS Biomater Sci Eng. 2019; 5: 1534-43.

[30] Chu D, Dong X, Shi X, Zhang C, Wang Z. Neutrophil-based drug delivery systems. Adv Mater. 2018; 30: e1706245.

[31] Che J, Najer A, Blakney AK, McKay PF, Bellahcene M, Winter CW, et al. Neutrophils enable local and non-invasive liposome delivery to inflamed skeletal muscle and ischemic heart. Adv Mater. 2020; 32: e2003598.

[32] Zhang J, Ji C, Zhang H, Shi H, Mao F, Qian H, et al. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy. Sci Adv. 2022; 8: eabj8207.

[33] Van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018; 19: 213-28.

[34] Ragland SA, Criss AK. From bacterial killing to immune modulation: recent insights into the functions of lysozyme. PLoS Pathog. 2017; 13: e1006512.

[35] Chen LL, Shi WP, Zhang TD, Zhou YQ, Zhao FZ, Ge WY, et al. Antibacterial activity of lysozyme-loaded cream against MRSA and promotion of scalded wound healing. Int J Pharm. 2022; 627: 122200.

[36] Ye H, Wang F, Xu G, Shu F, Fan K, Wang D. Advancements in engineered exosomes for wound repair: current research and future perspectives. Front Bioeng Biotechnol. 2023; 11: 1301362.

[37] Genschmer KR, Russell DW, Lal C, Szul T, Bratcher PE, Noerager BD, et al. Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung. Cell. 2019; 176: 113-126.e15.